RxDoctor Payments Data

Amanda Burkheart, DO

Family Medicine · Union, MONPI 1912134834

Payments from drug & device makers

$1,093in general payments, 2019–2025

Across 54 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$328
  • Pfizer$182
  • Novartis$130
  • GSK$124
  • Novo Nordisk$94
  • Dexcom, Inc.$84
  • plus $152 from 5 others

What the payments were for

  • Food & beverage$1,093100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,093 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$47,455
Medicare patients
120
Services billed
592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin110$133,373
TrulicityDulaglutide72$118,479
OzempicSemaglutide75$110,748
EliquisApixaban77$99,731
MounjaroTirzepatide47$63,839
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$26,185
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$24,477
XareltoRivaroxaban22$22,026
Spiriva RespimatTiotropium Bromide19$14,870
FarxigaDapagliflozin Propanediol22$11,557
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$10,355
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$7,414
MyrbetriqMirabegron13$7,324
Atorvastatin Calcium625$6,759
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$6,703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$74$182,318119 claims
Novo NordiskOzempic$94$110,74875 claims
PfizerEliquis$182$99,73177 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$124$38,60480 claims
Johnson & JohnsonXarelto$16$22,02622 claims
AstraZenecaFarxiga, Symbicort$26$16,12536 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Union

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →